SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-042039
Filing Date
2024-10-03
Accepted
2024-10-03 11:12:38
Documents
14
Period of Report
2024-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20241003.htm   iXBRL 8-K 32126
  Complete submission text file 0001628280-24-042039.txt   158143

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20241003.xsd EX-101.SCH 2186
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20241003_def.xml EX-101.DEF 3361
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20241003_lab.xml EX-101.LAB 21903
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20241003_pre.xml EX-101.PRE 13177
16 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20241003_htm.xml XML 2446
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 241350347
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)